Cargando…
SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model
SARS-CoV-2 and its emerging variants of concern remain a major threat for global health. Here we introduce an infection model based upon polarized human Alveolar Epithelial Lentivirus immortalized (hAELVi) cells grown at the air–liquid interface to estimate replication and epidemic potential of resp...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610361/ https://www.ncbi.nlm.nih.gov/pubmed/36302956 http://dx.doi.org/10.1038/s42003-022-04068-3 |
_version_ | 1784819250142117888 |
---|---|
author | Mache, Christin Schulze, Jessica Holland, Gudrun Bourquain, Daniel Gensch, Jean-Marc Oh, Djin-Ye Nitsche, Andreas Dürrwald, Ralf Laue, Michael Wolff, Thorsten |
author_facet | Mache, Christin Schulze, Jessica Holland, Gudrun Bourquain, Daniel Gensch, Jean-Marc Oh, Djin-Ye Nitsche, Andreas Dürrwald, Ralf Laue, Michael Wolff, Thorsten |
author_sort | Mache, Christin |
collection | PubMed |
description | SARS-CoV-2 and its emerging variants of concern remain a major threat for global health. Here we introduce an infection model based upon polarized human Alveolar Epithelial Lentivirus immortalized (hAELVi) cells grown at the air–liquid interface to estimate replication and epidemic potential of respiratory viruses in the human lower respiratory tract. hAELVI cultures are highly permissive for different human coronaviruses and seasonal influenza A virus and upregulate various mediators following virus infection. Our analysis revealed a significantly reduced capacity of SARS-CoV-2 Omicron BA.1 and BA.2 variants to propagate in this human model compared to earlier D614G and Delta variants, which extends early risk assessments from epidemiological and animal studies suggesting a reduced pathogenicity of Omicron. |
format | Online Article Text |
id | pubmed-9610361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96103612022-10-28 SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model Mache, Christin Schulze, Jessica Holland, Gudrun Bourquain, Daniel Gensch, Jean-Marc Oh, Djin-Ye Nitsche, Andreas Dürrwald, Ralf Laue, Michael Wolff, Thorsten Commun Biol Article SARS-CoV-2 and its emerging variants of concern remain a major threat for global health. Here we introduce an infection model based upon polarized human Alveolar Epithelial Lentivirus immortalized (hAELVi) cells grown at the air–liquid interface to estimate replication and epidemic potential of respiratory viruses in the human lower respiratory tract. hAELVI cultures are highly permissive for different human coronaviruses and seasonal influenza A virus and upregulate various mediators following virus infection. Our analysis revealed a significantly reduced capacity of SARS-CoV-2 Omicron BA.1 and BA.2 variants to propagate in this human model compared to earlier D614G and Delta variants, which extends early risk assessments from epidemiological and animal studies suggesting a reduced pathogenicity of Omicron. Nature Publishing Group UK 2022-10-27 /pmc/articles/PMC9610361/ /pubmed/36302956 http://dx.doi.org/10.1038/s42003-022-04068-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Mache, Christin Schulze, Jessica Holland, Gudrun Bourquain, Daniel Gensch, Jean-Marc Oh, Djin-Ye Nitsche, Andreas Dürrwald, Ralf Laue, Michael Wolff, Thorsten SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model |
title | SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model |
title_full | SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model |
title_fullStr | SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model |
title_full_unstemmed | SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model |
title_short | SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model |
title_sort | sars-cov-2 omicron variant is attenuated for replication in a polarized human lung epithelial cell model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610361/ https://www.ncbi.nlm.nih.gov/pubmed/36302956 http://dx.doi.org/10.1038/s42003-022-04068-3 |
work_keys_str_mv | AT machechristin sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel AT schulzejessica sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel AT hollandgudrun sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel AT bourquaindaniel sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel AT genschjeanmarc sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel AT ohdjinye sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel AT nitscheandreas sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel AT durrwaldralf sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel AT lauemichael sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel AT wolffthorsten sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel |